Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07011485
PHASE2

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

Sponsor: PDFE Pharma Innovations FZCO

View on ClinicalTrials.gov

Summary

This study will evaluate the safety and efficacy of PDFE-2304 compared with Minoxidil 5% in men with androgenic alopecia (AGA).

Official title: A Triple-Blind, Randomized, Efficacy and Tolerability Comparison Study of PDFE-2304 Topical Solution Versus Minoxidil 5% Topical Solution for the Treatment of Androgenic Alopecia (AGA).

Key Details

Gender

MALE

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2025-05-14

Completion Date

2025-09-17

Last Updated

2025-06-08

Healthy Volunteers

No

Interventions

DRUG

Minoxidil 5% Topical Solution

Approximately one mL dose applied onto a pre-specified scalp area twice daily for 16 weeks.

DRUG

PDFE-2304 Topical Solution

Approximately one mL dose applied onto a pre-specified scalp area twice daily for 16 weeks.

Locations (1)

Koppal Institute of Medical Sciences

Koppal, Karnataka, India